USC PhD student Ruzanna “Rose” Shkhyan has gotten a first-hand look at how stem cell discoveries can lead to clinical trials. As member of the USC Stem Cell laboratory of Denis Evseenko, she contributed research that led to the development of a therapeutic agent that can modulate inflammation, which will be in a clinical trial…Continue Reading PhD Student Ruzanna “Rose” Shkhyan works to end inflamm-aging
Year: 2020
Lab publishes study in Arthritis & Rheumatology
A novel preclinical study from the Evseenko Lab, published in Arthritis & Rheumatology, reveals that a potential new opioid medication may have the ability to slow the progression of osteoarthritis while being less addictive than commonly prescribed opioid drugs. The medication activates the kappa opioid receptor (KOR), which binds to opioid-like compounds in the central…Continue Reading Lab publishes study in Arthritis & Rheumatology
USC scientists use “mini-lungs” and lung models to understand COVID-19
USC scientists are testing out experimental COVID-19 treatments on human “mini-lungs” and lung models, grown in the laboratory using stem cells. With names such as organoids and lung-chips, these simplified, lung-like structures are critically useful for studying infection and for screening large numbers of drug-like molecules to identify promising leads. To read more about these…Continue Reading USC scientists use “mini-lungs” and lung models to understand COVID-19